نتائج البحث

Effects of ketoconazole on the pharmacokinetics of lenvatinib (E7080) in healthy participants حسب Robert Shumaker, Jagadeesh Aluri, Jean Fan, Gresel Martinez, Gary A. Thompson, Min Ren

احصل على النص الكامل احصل على النص الكامل

Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development حسب Qingyang Gu, Bin Zhang, Hongye Sun, Qiang Xu, Yexiong Tan, Guan Wang, Qin Luo, Weiguo Xu, Shuqun Yang, Jian Li, Jing Fu, Lei Chen, Shengxian Yuan, Gui‐Bai Liang, Qunsheng Ji, Shuhui Chen, Chi-Chung Chan, Weiping Zhou, Xiaowei Xu, Hongyang Wang, Douglas D. Fang

احصل على النص الكامل احصل على النص الكامل

A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine‐refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment حسب Maria E. Cabanillas, Martin Schlumberger, Barbara Jarząb, Renato Martins, Furio Pacini, Bruce Robinson, Judith C. McCaffrey, Manisha H. Shah, Donald Bodenner, Duncan J. Topliss, Corina Andresen, James P. O’Brien, Min Ren, Yasuhiro Funahashi, Roger Allison, Rossella Elisei, Kate Newbold, Lisa Licitra, Steven I. Sherman, Douglas W. Ball

احصل على النص الكامل

Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma حسب Masafumi Ikeda, Takuji Okusaka, Shuichi Mitsunaga, Hideki Ueno, Toshiyuki Tamai, Takuya Suzuki, Seiichi Hayato, Tadashi Kadowaki, Kiwamu Okita, Hiromitsu Kumada

احصل على النص الكامل

New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions حسب Makoto Chuma, Katsumi Terashita, Naoya Sakamoto

احصل على النص الكامل احصل على النص الكامل

Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine‐refractory differentiated thyroid cancer حسب Naomi Kiyota, Martin Schlumberger, Kei Muro, Yukio Ando, Shunji Takahashi, Yasukazu Kawai, Lori J. Wirth, Bruce Robinson, Steven I. Sherman, Takuya Suzuki, Katsuki Fujino, Anubha Gupta, Seiichi Hayato, Makoto Tahara

احصل على النص الكامل احصل على النص الكامل

Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer حسب Martin Schlumberger, Makoto Tahara, Lori J. Wirth, Bruce Robinson, Marcia S. Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H. Shah, Ana O. Hoff, Andrew G. Gianoukakis, Naomi Kiyota, Matthew H. Taylor, Sung‐Bae Kim, Monika K. Krzyzanowska, Corina E. Dutcus, Begoña de las Heras, Junming Zhu, Steven I. Sherman

احصل على النص الكامل احصل على النص الكامل

A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer حسب Martin Schlumberger, Barbara Jarząb, Maria E. Cabanillas, Bruce Robinson, Furio Pacini, Douglas W. Ball, Judith C. McCaffrey, Kate Newbold, Roger Allison, Renato Martins, Lisa Licitra, Manisha H. Shah, Donald Bodenner, Rossella Elisei, Lynn A. Burmeister, Yasuhiro Funahashi, Min Ren, James P. O'Brien, Steven I. Sherman

احصل على النص الكامل

Distinct Binding Mode of Multikinase Inhibitor Lenvatinib Revealed by Biochemical Characterization حسب Kiyoshi Okamoto, Megumi Ikemori‐Kawada, A. Jestel, Konstanze von König, Yasuhiro Funahashi, Tomohiro Matsushima, Akihiko Tsuruoka, Atsushi Inoue, Junji Matsui

احصل على النص الكامل

Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications حسب Catherine Frenette

احصل على النص الكامل

Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options حسب Francesco Perri

احصل على النص الكامل

Effect of Rifampicin on the Pharmacokinetics of Lenvatinib in Healthy Adults حسب Robert Shumaker, Jagadeesh Aluri, Jean Fan, Gresel Martinez, Gary A. Thompson, Min Ren

احصل على النص الكامل احصل على النص الكامل

Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib حسب Jaume Capdevila, Neda Stjepanovic

احصل على النص الكامل احصل على النص الكامل

Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions حسب Furio Pacini, Yasuhiro Ito, Markus Luster, Fabián Pitoia, Bruce Robinson, Lori J. Wirth

احصل على النص الكامل احصل على النص الكامل

Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models حسب Kiyoshi Okamoto, Kotaro Kodama, Kazuma Takase, Naoko Hata Sugi, Yuji Yamamoto, Masao Iwata, Akihiko Tsuruoka

احصل على النص الكامل

Antitumor Activity of Lenvatinib (E7080): An Angiogenesis Inhibitor That Targets Multiple Receptor Tyrosine Kinases in Preclinical Human Thyroid Cancer Models حسب Osamu Tohyama, Junji Matsui, Kotaro Kodama, Naoko Hata-Sugi, Takayuki Kimura, Kiyoshi Okamoto, Yukinori Minoshima, Masao Iwata, Yasuhiro Funahashi

احصل على النص الكامل احصل على النص الكامل

A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC) حسب Ana M. Molina, Thomas E. Hutson, James Larkin, Anne Gold, Karen Wood, Dave Carter, Robert J. Motzer, M. Dror Michaelson

احصل على النص الكامل احصل على النص الكامل

Differentiated Thyroid Cancer: Focus on Emerging Treatments for Radioactive Iodine-Refractory Patients حسب Joshua J. Gruber, A. Dimitrios Colevas

احصل على النص الكامل

Management of Sorafenib-Related Adverse Events: A Clinician’s Perspective حسب Marcia S. Brose, Catherine Frenette, Stephen J. O’Keefe, Stacey Stein

احصل على النص الكامل

Influence of hepatic impairment on lenvatinib pharmacokinetics following single‐dose oral administration حسب Robert Shumaker, Jagadeesh Aluri, Jean Fan, Gresel Martinez, Helen S. Pentikis, Min Ren

احصل على النص الكامل احصل على النص الكامل